Moreover, subsequent analyses indicated albiflorin could exert its effects by inhibiting PC12 cell apoptosis via the MAPK/ERK pathway, thereby offering potential therapeutic benefits for AD treatment [29]. This evidence concerns the gene MAPK1 and Alzheimer disease.